News

We are pleased to announce the new AllplexTM SARS-CoV-2 Master Assay from Seegene today.

We are happy to announce that BÜHLMANN Laboratories AG has two new, attractive SARS-CoV-2 Antigen (Ag) rapid tests in its portfolio.

BÜHLMANN Laboratories is proud to announce the addition of the CE marked Quantum Blue^® Anti-Adalimumab to our TDM rapid test portfolio.

At the virtual AACC 2020 BÜHLMANN had the great opportunity to present two posters about the Quantum Blue^® Infliximab.